• 1
    Castillo J, Davalos A, Marrugat J, Noya M. Timing for fever-related brain damage in acute ischemic stroke. Stroke 1998; 29:24552460.
  • 2
    Wang Y, Lim LL, Levi C, Heller RF, Fisher J. Influence of admission body temperature on stroke mortality. Stroke 2000; 31:404409.
  • 3
    Reith J, Jorgensen HS, Pedersen PM et al. Body temperature in acute stroke: relation to stroke severity, infarct size, mortality, and outcome. Lancet 1996; 347:422425.
  • 4
    Foundation NS. National Stroke Audit – Acute Services Clinical Audit Report 2011. Melbourne, Australia, National Stroke Foundation, 2011.
  • 5
    Gentile NT, Seftchick MW, Huynh T, Kruus LK, Gaughan J. Decreased mortality by normalizing blood glucose after acute ischemic stroke. Acad Emerg Med 2006; 13:174180.
  • 6
    Williams LS, Rotich J, Fineberg N et al. Effects of admission hyperglycemia on mortality and costs in acute ischemic stroke. Neurology 2002; 59:6771.
  • 7
    Martino R, Foley N, Bhogal S, Diamant N, Speechley M, Teasell R. Dysphagia after stroke: incidence, diagnosis, and pulmonary complications. Stroke 2005; 36:27562763.
  • 8
    Hajat C, Hajat S, Sharma P. Effects of poststroke pyrexia on stroke outcome: a meta-analysis of studies in patients. Stroke 2000; 31:410414.
  • 9
    Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 2001; 32:24262432.
  • 10
    Scott JF, Robinson GM, French JM, O'Connell JE, Alberti KGMM, Gray CS. Prevalence of admission hyperglycaemia across clinical subtypes of acute stroke. Lancet 1999; 353:376377.
  • 11
    Carnaby G, Hankey GJ, Pizzi J. Behavioural intervention for dysphagia in acute stroke: a randomised controlled trial. Lancet Neurol 2006; 5:3137.
  • 12
    Den Hertog HM, van der Worp HB, van Gemert HMA et al. The Paracetamol (Acetaminophen) In Stroke (PAIS) trial: a multicentre, randomised, placebo-controlled, phase III trial. Lancet Neurol 2009; 8:434440.
  • 13
    Gray CS, Hildreth AJ, Sandercock PA et al. Glucose-potassium-insulin infusions in the management of post-stroke hyperglycaemia: the UK Glucose Insulin in Stroke Trial (GIST-UK). Lancet Neurol 2007; 6:397406.
  • 14
    Bernhardt J, Dewey H, Thrift A, Collier J, Donnan G. A Very Early Rehabilitation Trial for stroke (AVERT): phase II safety and feasibility. Stroke 2008; 39:390396.
  • 15
    Weinhardt J, Hazelett S, Barrett D, Lada R, Enos T, Keleman R. Accuracy of a bedside dysphagia screening: a comparison of registered nurses and speech therapists. Rehabil Nurs 2008; 33:247252.
  • 16
    Turner-Lawrence DE, Peebles M, Price MF, Singh SJ, Asimos AW. A feasibility study of the sensitivity of emergency physician dysphagia screening in acute stroke patients. Ann Emerg Med 2009; 54:344348.
  • 17
    Hinchey JA, Shephard T, Furie K, Smith D, Wang D, Tonn S. Formal dysphagia screening protocols prevent pneumonia. Stroke (American Heart Association) 2005; 36:19721976.
  • 18
    National Stroke Foundation. Clinical Guidelines for Stroke Management 2010. Victoria, NSF, 2010.
  • 19
    National Institute for Health and Clinical Excellence. Diagnosis and Initial Management of Acute Stroke and Transient Ischemic Attack (TIA). London, National Institute for Health & Clinical Excellence, 2008.
  • 20
    Adams H, Adams R, Del Zoppo G, Goldstein LB. Stroke Council of the American Heart Association, American Stroke Association. Guidelines for the early management of patients with ischemic stroke: 2005 guidelines update a scientific statement from the Stroke Council of the American Heart Association/American Stroke Association. Stroke 2005; 36:916923.
  • 21
    European Stroke Organisation (ESO) Executive Committee, ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 2008; 25:457507.
  • 22
    Lindsay P, Bayley M, Hellings C, Hill M, Woodbury E, Phillips S. Canadian best practice recommendations for stroke care. CMAJ 2008; 179:S125.
  • 23
    National Stroke Foundation. Clinical Guidelines for Acute Stroke Managment. Victoria, NSF, 2007.
  • 24
    Middleton S, McElduff P, Ward J et al. Implementation of evidence-based treatment protocols to manage fever, hyperglycaemia, and swallowing dysfunction in acute stroke (QASC): a cluster randomised controlled trial. Lancet 2011; 378:16991706.
  • 25
    Middleton S, Levi C, Griffiths R, Grimshaw J, Ward J. Quality in Acute Stroke Care Project – protocol for a clustered randomised control trial to evaluate the management of fever, sugar and swallowing dysfunction (FeSS) following acute stroke. Intern Med J 2006; 36:A1.
  • 26
    Cadilhac DA, Lalor EE, Pearce DC, Levi CR, Donnan GA. Access to stroke care units in Australian public hospitals: facts and temporal progress. Intern Med J 2006; 36:700704.
  • 27
    Aerden L, Luijckx GJ, Ricci S, Hilton A, Kessels F, Lodder J. Validation of the Oxfordshire Community Stroke Project syndrome diagnosis derived from a standard symptom list in acute stroke. J Neurol Sci 2004; 220:5558.
  • 28
    Lindenstrom E, Boysen G, Christiansen L, Hansen B, Nielsen P. Reliability of Scandinavian neurological stroke scale. Cardiovasc Dis 1991; 1:103107.
  • 29
    De Haan R, Limburg M, Bossuyt P, Van der Meulen J, Aaronson N. The clinical meaning of Rankin ‘handicap’ grades after stroke. Stroke 1995; 26:20272030.
  • 30
    NSW Health Policy Directive: Paracetamol Use. Department of Health, NSW Australia, 2009; 118.
  • 31
    Conover WJ. Practical Non-Parametric Statistics. New York, Wiley, 1999.
  • 32
    Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 1991; 337:15211526.
  • 33
    Wang CX, Stroink A, Casto JM, Kattner K. Hyperthermia exacerbates ischaemic brain injury. Int J Stroke 2009; 4:274284.
  • 34
    Greer DM, Funk SE, Reaven NL, Ouzounelli M, Uman GC. Impact of fever on outcome in patients with stroke and neurologic injury: a comprehensive meta-analysis. Stroke 2008; 39:30293035.
  • 35
    Azzimondi G, Bassein L, Nonino F et al. Fever in acute stroke worsens prognosis. A prospective study. Stroke 1995; 26:20402043.
  • 36
    Kammersgaard LP, Jorgensen HS, Rungby JA et al. Admission body temperature predicts long-term mortality after acute stroke: the Copenhagen Stroke Study. Stroke 2002; 33:17591762.
  • 37
    Dippel DW, van Breda EJ, van der Worp HB et al. Effect of paracetamol (acetaminophen) and ibuprofen on body temperature in acute ischemic stroke PISA, a phase II double-blind, randomized, placebo-controlled trial. BMC Cardiovasc Disord 2003; 3:2.
  • 38
    Naidech A, Bendok B, Bernstein R, Alberts M, Batjer H, Watts C. Fever burden and functional recovery after subarachnoid hemorrhage. Neurosurgery 2008; 63:212218.
  • 39
    Phipps MA, Desai R, Wira C, Bravata DM. Epidemiology and outcomes of fever burden among patients with acute ischemic stroke. Stroke 2011; 42:16.
  • 40
    Fuentes B, Ortega-Casarrubios MA, Sanjose B et al. Persistent hyperglycemia >155 mg/dL in acute ischemic stroke patients: how well are we correcting It?: implications for outcome. Stroke 2010; 41:23622365.
  • 41
    Saini M, Saqqur M, Kamruzzaman A, Lees K, Shuaib A. Effect of hyperthermia on prognosis after acute ischemic stroke. Stroke 2009; 40:30513059.
  • 42
    Grimshaw JM, Thomas RE, MacLennan G et al. Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technol Assess 2004; 8:172.